INJECTION COMPOSITIONS FOR CARRYING OUT CONTROLLABLE PHARMACOLOGICALLY ACTIVE COMPOSITION DELIVERY

FIELD: medical engineering. ^ SUBSTANCE: preparation has pharmacologically active compound salt having lipophilic counter-ion and pharmaceutically permissible water-soluble solvent combined into injectable composition. The lipophilic counter-ion is known to be a saturated or unsaturated C8-C22-fatty...

Full description

Saved in:
Bibliographic Details
Main Authors SUVA ROBERT, MURTI JERRAMILLI V. S. N
Format Patent
LanguageEnglish
Russian
Published 10.02.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:FIELD: medical engineering. ^ SUBSTANCE: preparation has pharmacologically active compound salt having lipophilic counter-ion and pharmaceutically permissible water-soluble solvent combined into injectable composition. The lipophilic counter-ion is known to be a saturated or unsaturated C8-C22-fatty acid and, in preferable version, saturated or unsaturated C10-C18-fatty acid. When making injection to mammal animal, at least some part of the composition precipitates and releases active compound in time. The composition forms active compound depot in this way with delayed release. ^ EFFECT: controlled and prolonged drug action in organism up to 15 days long period of time; wide range of functional applications. ^ 63 cl, 10 dwg, 1 tbl
Bibliography:Application Number: RU20040115103